The Patent Finder

Baxter Trading GmbH

Also on record
Records under this name other than patents Baxter Trading GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Baxter Trading GmbH

PatentTitleStatus Expires Confidence
US 7,033,590Factor IX/factor IXa activating antibodies and antibody derivatives
Formerly held
Term ended
Term ended Dec 20, 2021 · From the USPTO record
Term endedTerm ended Dec 20, 2021From the USPTO record
US 6,958,322Factor X analog with an improved ability to be activated
Formerly held
Term ended
Term ended Sep 3, 2021 · From the USPTO record
Term endedTerm ended Sep 3, 2021From the USPTO record
US 6,974,792Alpha 1-Antitrypsin Preparation as Well as a Method for Producing the Same
Formerly held
Term ended
Term ended Jun 10, 2021 · Medium confidence
Term endedTerm ended Jun 10, 2021Medium confidence
US 8,709,492Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metals
Formerly held
Term ended
Term ended May 4, 2021 · Medium confidence
Term endedTerm ended May 4, 2021Medium confidence
US 7,241,603Method for Producing a Preparation Based on Fibrinogen and Fibronectin as Well as Protein Compositions Obtainable According to This Method
Formerly held
Term ended
Term ended Dec 1, 2020 · Medium confidence
Term endedTerm ended Dec 1, 2020Medium confidence
US 6,506,365Fibrin/fibrinogen binding conjugate
Formerly held
Term ended
Term ended Sep 25, 2020 · From the USPTO record
Term endedTerm ended Sep 25, 2020From the USPTO record
US 6,713,453Fibrin/Fibrinogen-Binding Conjugate
Formerly held
Term ended
Term ended Sep 25, 2020 · Medium confidence
Term endedTerm ended Sep 25, 2020Medium confidence
US 7,091,325Fibrin/Fibrinogen-Binding Conjugate
Formerly held
Term ended
Ended no later than Sep 25, 2020 · Low confidence
Term endedEnded no later than Sep 25, 2020Low confidence
US 7,279,161Factor IX/Factor Ixa Activating Antibodies and Antibody Derivatives
Formerly held
Term ended
Term ended Sep 14, 2020 · Medium confidence
Term endedTerm ended Sep 14, 2020Medium confidence
US 9,441,203Medium for the Protein-Free and Serum-Free Cultivation of Cells
Formerly held
Lapsed on the fee record
Ended Sep 13, 2020 · Low confidence
Lapsed on the fee recordEnded Sep 13, 2020Low confidence
10 of 65 patents shown.
Pro members see all 65.
Pro members: see all 65 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited